IVAL is named as a semi-finalist in the “Transform Tox Testing Challenge” created to improve chemical screening.

IVAL continues its series of innovative approaches to the comprehensive understanding of toxicity. The Transform Tox Testing Challenge was created by a coalition of Federal Agencies: the Environmental Protection Agency (EPA) and the National Institutes of Health (NIH) the National Center for Advancing Translational Sciences (NCTAS), National Institutes of Health NIH’s Nation Toxicology Program (NPA) within the National Institute of Environmental Health Sciences (NIEHS). The purpose of the challenge is to more fully evaluate the potential harmful effects of chemicals found in the environment by using High Throughput Screening (HTS) approaches.

IVAL has developed a unique patent-pending approach using the Exogenous Metabolism System (EXM). The EXM consists of a transwell insert containing human or animal hepatocytes. The EXM insert is placed into a cell culture well containing the target cells used for toxicity evaluation, serving as an exogenous hepatic metabolic system.

For more information on the Tox Testing Challenge, Please visit http://transformtoxtesting.com